glp 1 agonist alternative GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 receptor agonists review and

-1 : The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

Theres also a similar class of medications called dual GLP-1 and GIP receptor agonists, and tirzepatide (the generic name for Mounjaro and Zepbound) is the only drug available in the U.S

Saltiel AR, Kahn CR

Lau DC, Teoh H

He hasnt lost weight

Novo Nordisk is committed to the responsible use of our semaglutide-containing medicines which represent distinct products with different indications, dosages, prescribing information, titration schedules, and delivery forms